Karus CEO Highlights Niche Indications For Oncology Innovation
Executive Summary
Karus Therapeutics CEO, Simon Kerry, talks to Scrip senior writer, Lucie Ellis, during the recent BIO-Europe partnering meeting about the company’s cancer-focused pipeline and where its products will sit within the crowded oncology market space.